|1.||Faucher, Catherine: 3 articles (11/2014 - 12/2010)|
|2.||Castagna, Luca: 3 articles (11/2014 - 12/2010)|
|3.||Chabannon, Christian: 3 articles (11/2014 - 12/2010)|
|4.||Blaise, Didier: 3 articles (11/2014 - 12/2010)|
|5.||Bacigalupo, Andrea: 3 articles (06/2012 - 05/2006)|
|6.||Brennan, Daniel C: 3 articles (10/2008 - 07/2004)|
|7.||Enkvetchakul, Decha: 3 articles (10/2008 - 07/2004)|
|8.||Schnitzler, Mark A: 3 articles (10/2008 - 07/2004)|
|9.||Miller, Brent: 3 articles (10/2008 - 07/2004)|
|10.||Hardinger, Karen L: 3 articles (10/2008 - 07/2004)|
01/01/2013 - "The induction with thymoglobulin was associated with four times greater risk of developing CMV infection (adjusted hazard ratio: AHR 4.15, 95% 1.75, 9.86, P = .001). "
01/01/2013 - "Kaplan-Meier and multivariate Cox proportional regression analyses were employed to compare the risk of CMV infection between patients with and without the use of thymoglobulin induction. "
01/01/2013 - "The use of T-cell-depleting antibody, such as thymoglobulin, is a risk factor for cytomegalovirus (CMV) infection. "
04/01/2006 - "We conclude that thymoglobulin reverses acute rejection in HIV-infected kidney recipients, but produces profound and long-lasting suppression of the CD4+ T-cell count associated with increased risk of infections requiring hospitalization."
04/01/2006 - "We studied thymoglobulin's effect on CD4+ T-cell count, risk of infection and rejection reversal in 20 consecutive HIV-infected kidney recipients. "
|2.||Graft vs Host Disease (Graft-Versus-Host Disease)
05/01/2012 - "The optimal dose and schedule of thymoglobulin (ATG) for graft-versus-host disease prevention (GVHD) is unknown. "
11/01/2010 - "Among the many kinds of ATG preparations, thymoglobulin had been found to be more effective for preventing graft-versus-host disease (GVHD) and the rejection of organ transplants. "
04/01/2015 - "To prevent graft-versus-host disease and rejection in hematopoietic cell transplantation (HCT), children receive Thymoglobulin(®), a polyclonal antibody acting mainly by depleting T cells. "
04/01/2007 - "Unrelated stem cell transplantation after a reduced intensity conditioning regimen containing high-dose thymoglobulin leads to controllable graft-versus-host disease."
07/15/2004 - "Thymoglobulin given before allo-hematopoietic stem-cell transplantation (HSCT) from unrelated donors reduces acute graft-versus-host disease (GvHD), but the optimal dose is unknown. "
|3.||Cytomegalovirus Infections (Inclusion Disease)
09/01/2013 - "This review concluded that compared to ATG-F, Thymoglobulin possibly provides better protection against acute rejection and improves patient and graft survival but may result in more cytomegalovirus infection and post-transplant malignancy. "
06/01/2010 - "Therefore, in this study, we retrospectively compared the effect of two different rabbit ATG preparations [Thymoglobulin (ATG-G) and ATG-Fresenius (ATG-F)] on immune recovery and cytomegalovirus infection after transplantation. "
10/01/2008 - "Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates."
08/01/2013 - "Incidences of Cytomegalovirus infection, leucopenia, and thrombocytopenia were significantly higher in the thymoglobulin group (P < .05). "
06/01/2004 - "Cytomegalovirus infection accounted for a significantly smaller proportion of this cost in the Simulect arm than in the Thymoglobulin arm (30% vs. 53%, p = 0.001). "
01/01/2005 - "Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy."
01/01/2005 - "Thymoglobulin allowed for more compromised liver grafts to be transplanted with less clinical evidence of ischemia reperfusion injury and improved function."
01/01/2005 - "This controlled randomized trial was designed to assess whether thymoglobulin also protects liver transplant recipients from ischemia reperfusion injury. "
09/01/2007 - "Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation."
08/01/2005 - "Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury."
|5.||Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/01/2014 - "Two patients had received extra immunosuppression (1 with thymoglobulin to treat an acute rejection and the other 1 had a lymphoproliferative disorder and was on chemotherapy). "
06/01/2011 - "Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review."
03/01/2015 - "Company reply to "Unexpected outbreak of Epstein-Barr virus post-transplantation lymphoproliferative disorder after hematopoietic stem cell transplantation conditioning with thymoglobulin"."
09/01/2014 - "Unexpected outbreak of Epstein-Barr virus post-transplantation lymphoproliferative disorder after hematopoietic stem cell transplantation conditioning with thymoglobulin."
10/15/2008 - "There were no posttransplant lymphoproliferative disorder in the thymoglobulin group and there were two cases in the Atgam group. "
|1.||Antilymphocyte Serum (Anti-Thymocyte Globulin)
|6.||mycophenolate mofetil (Cellcept)
|7.||Muromonab-CD3 (Muromonab CD3)
|9.||Dihydrotachysterol (AT 10)
|10.||fludarabine monophosphate (Fludara)
|2.||Transplantation (Transplant Recipients)
|3.||Homologous Transplantation (Allograft)
|5.||Stem Cell Transplantation